Movement Alert|Rocket Lab USA, Inc. Rises 5.66% in Pre-Market Trading, Launches Next-Gen Germanium-Free Solar Cell for Space

Market Focus
Yesterday

On September 9, Rocket Lab USA, Inc. rose 5.66% in pre-market trading, trading at approximately $69.47/share, with turnover of $14.58 million. The rally was driven by the company's announcement of IMM Apex, a next-generation solar cell designed specifically for space applications.

The IMM Apex cell achieves 31.5% beginning-of-life conversion efficiency with 40% lower cell mass, and completely eliminates the germanium substrates used in conventional multi-junction solar cells. This innovation directly addresses rising costs and supply chain bottlenecks in the space power industry. The product is available immediately and can be manufactured in multi-100-kilowatt volumes, serving as a mechanical and electrical drop-in replacement for existing germanium-based products.

The announcement builds on recent positive momentum for the company, which was onboarded to the U.S. Space Force's $981 million NITE-STAR program in August and secured over $437 million in new launch contracts during Q2. ARK Invest also notably added 505,000 shares on September 2. Analysts maintain a consensus overweight rating with a mean price target of approximately $113.77.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10